Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

7.10
Delayed Data
As of Jun 27
 -0.21 / -2.87%
Today’s Change
5.90
Today|||52-Week Range
25.17
-30.93%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close7.31
Today’s open7.31
Day’s range7.00 - 7.42
Volume749,996
Average volume (3 months)851,269
Market cap$207.5M
Dividend yield--
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)-108.51%
Earnings growth (this year)+3.06%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.78%
P/E ratioNM
Price/Sales8.33
Price/Book1.60

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...+0.21+5.30%
URGNUrogen Pharma Ltd+0.37+1.90%
DRRXDURECT Corp+0.04+2.67%
ABUSArbutus Biopharma Co...-0.20-5.41%
Data as of 06/27/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$35.8M
Annual profit (last year)-$85.2M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts